<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-08-30" modified="2017-05-10" version="160">
<accession>O00443</accession>
<accession>B0LPH2</accession>
<accession>B4E2G4</accession>
<accession>Q14CQ9</accession>
<name>P3C2A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha</fullName>
<shortName>PI3K-C2-alpha</shortName>
<shortName>PtdIns-3-kinase C2 subunit alpha</shortName>
<ecNumber>2.7.1.154</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Phosphoinositide 3-kinase-C2-alpha</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PIK3C2A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Biochem. J." volume="326" first="139" last="147">
<title>Cloning of a human phosphoinositide 3-kinase with a C2 domain which displays reduced sensitivity to the inhibitor wortmannin.</title>
<authorList>
<person name="Domin J."/>
<person name="Pages F."/>
<person name="Volinia S."/>
<person name="Rittenhouse S.E."/>
<person name="Zvelebil M.J."/>
<person name="Stein R.C."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="9337861"/>
<dbReference type="DOI" id="10.1042/bj3260139"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>COFACTOR</scope>
<scope>ENZYME REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2007-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="11943" last="11950">
<title>The class II phosphoinositide 3-kinase PI3K-C2alpha is concentrated in the trans-Golgi network and present in clathrin-coated vesicles.</title>
<authorList>
<person name="Domin J."/>
<person name="Gaidarov I."/>
<person name="Smith M.E.K."/>
<person name="Keen J.H."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="10766823"/>
<dbReference type="DOI" id="10.1074/jbc.275.16.11943"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3817" last="3830">
<title>Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.</title>
<authorList>
<person name="Arcaro A."/>
<person name="Zvelebil M.J."/>
<person name="Wallasch C."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
<person name="Domin J."/>
</authorList>
<dbReference type="PubMed" id="10805725"/>
<dbReference type="DOI" id="10.1128/MCB.20.11.3817-3830.2000"/>
</citation>
<scope>FUNCTION</scope>
<scope>COFACTOR</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH ERBB2 AND EGFR</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="48135" last="48142">
<title>Phosphatidylinositol 3-kinase c2alpha contains a nuclear localization sequence and associates with nuclear speckles.</title>
<authorList>
<person name="Didichenko S.A."/>
<person name="Thelen M."/>
</authorList>
<dbReference type="PubMed" id="11606566"/>
<dbReference type="DOI" id="10.1074/jbc.M104610200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>PHOSPHORYLATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="443" last="449">
<title>The class II phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates clathrin-mediated membrane trafficking.</title>
<authorList>
<person name="Gaidarov I."/>
<person name="Smith M.E.K."/>
<person name="Domin J."/>
<person name="Keen J.H."/>
</authorList>
<dbReference type="PubMed" id="11239472"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00191-5"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CLATHRIN</scope>
<scope>MUTAGENESIS OF 103-LEU--ASP-107</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="BMC Clin. Pathol." volume="3" first="4" last="4">
<title>Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation.</title>
<authorList>
<person name="El Sheikh S.S."/>
<person name="Domin J."/>
<person name="Tomtitchong P."/>
<person name="Abel P."/>
<person name="Stamp G."/>
<person name="Lalani E.-N."/>
</authorList>
<dbReference type="PubMed" id="14563213"/>
<dbReference type="DOI" id="10.1186/1472-6890-3-4"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="26055" last="26064">
<title>Mitotic and stress-induced phosphorylation of HsPI3K-C2alpha targets the protein for degradation.</title>
<authorList>
<person name="Didichenko S.A."/>
<person name="Fragoso C.M."/>
<person name="Thelen M."/>
</authorList>
<dbReference type="PubMed" id="12719431"/>
<dbReference type="DOI" id="10.1074/jbc.M301657200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-259</scope>
<scope>MUTAGENESIS OF SER-254; SER-259; SER-262 AND SER-266</scope>
<scope>LACK OF PHOSPHORYLATION AT SER-244; SER-249; SER-251; SER-254; SER-262 AND SER-266</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="40766" last="40772">
<title>Individual phosphoinositide 3-kinase C2alpha domain activities independently regulate clathrin function.</title>
<authorList>
<person name="Gaidarov I."/>
<person name="Zhao Y."/>
<person name="Keen J.H."/>
</authorList>
<dbReference type="PubMed" id="16215232"/>
<dbReference type="DOI" id="10.1074/jbc.M507731200"/>
</citation>
<scope>FUNCTION IN ASSEMBLY AND CELLULAR DISTRIBUTION OF CLATHRIN</scope>
<scope>INTERACTION WITH CLATHRIN</scope>
<scope>MUTAGENESIS OF ASP-1250</scope>
<scope>REGION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108 AND SER-259</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-108; SER-259 AND SER-338</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="4240" last="4250">
<title>PI3KC2alpha, a class II PI3K, is required for dynamin-independent internalization pathways.</title>
<authorList>
<person name="Krag C."/>
<person name="Malmberg E.K."/>
<person name="Salcini A.E."/>
</authorList>
<dbReference type="PubMed" id="21081650"/>
<dbReference type="DOI" id="10.1242/jcs.071712"/>
</citation>
<scope>FUNCTION IN DYNAMIN-INDEPENDENT ENDOCYTOSIS</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108 AND SER-259</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="4216" last="4225">
<title>Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells.</title>
<authorList>
<person name="Dominguez V."/>
<person name="Raimondi C."/>
<person name="Somanath S."/>
<person name="Bugliani M."/>
<person name="Loder M.K."/>
<person name="Edling C.E."/>
<person name="Divecha N."/>
<person name="da Silva-Xavier G."/>
<person name="Marselli L."/>
<person name="Persaud S.J."/>
<person name="Turner M.D."/>
<person name="Rutter G.A."/>
<person name="Marchetti P."/>
<person name="Falasca M."/>
<person name="Maffucci T."/>
</authorList>
<dbReference type="PubMed" id="21127054"/>
<dbReference type="DOI" id="10.1074/jbc.M110.200295"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Biochem. Soc. Trans." volume="35" first="211" last="214">
<title>Role of class II phosphoinositide 3-kinase in cell signalling.</title>
<authorList>
<person name="Falasca M."/>
<person name="Maffucci T."/>
</authorList>
<dbReference type="PubMed" id="17371240"/>
<dbReference type="DOI" id="10.1042/BST0350229"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259 AND SER-327</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-259; SER-327; SER-630; SER-1281 AND SER-1553</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="39396" last="39406">
<title>Structural and membrane binding analysis of the Phox homology domain of phosphoinositide 3-kinase-C2alpha.</title>
<authorList>
<person name="Stahelin R.V."/>
<person name="Karathanassis D."/>
<person name="Bruzik K.S."/>
<person name="Waterfield M.D."/>
<person name="Bravo J."/>
<person name="Williams R.L."/>
<person name="Cho W."/>
</authorList>
<dbReference type="PubMed" id="17038310"/>
<dbReference type="DOI" id="10.1074/jbc.M607079200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1405-1544</scope>
<scope>PHOSPHOINOSITIDE BINDING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ARG-1488; VAL-1490; LEU-1491; ARG-1493 AND ARG-1503</scope>
</reference>
<reference key="28">
<citation type="submission" date="2006-10" db="PDB data bank">
<title>Ligand-binding specificity of PI3kinase C2alpha PX domain.</title>
<authorList>
<person name="Parkinson G.N."/>
<person name="Vines D."/>
<person name="Driscoll P.C."/>
<person name="Djordjevic S."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1421-1532</scope>
</reference>
<comment type="function">
<text evidence="19 20 21 23 25 27 29">Generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act as second messengers. Has a role in several intracellular trafficking events. Functions in insulin signaling and secretion. Required for translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane and glucose uptake in response to insulin-mediated RHOQ activation. Regulates insulin secretion through two different mechanisms: involved in glucose-induced insulin secretion downstream of insulin receptor in a pathway that involves AKT1 activation and TBC1D4/AS160 phosphorylation, and participates in the late step of insulin granule exocytosis probably in insulin granule fusion. Synthesizes PtdIns3P in response to insulin signaling. Functions in clathrin-coated endocytic vesicle formation and distribution. Regulates dynamin-independent endocytosis, probably by recruiting EEA1 to internalizing vesicles. In neurosecretory cells synthesizes PtdIns3P on large dense core vesicles. Participates in calcium induced contraction of vascular smooth muscle by regulating myosin light chain (MLC) phosphorylation through a mechanism involving Rho kinase-dependent phosphorylation of the MLCP-regulatory subunit MYPT1. May play a role in the EGF signaling cascade. May be involved in mitosis and UV-induced damage response. Required for maintenance of normal renal structure and function by supporting normal podocyte function.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + 1-phosphatidyl-1D-myo-inositol 4-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="20 29">
<name>Ca(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29108"/>
</cofactor>
<cofactor evidence="20 29">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<text evidence="20 29">Ca(2+) or Mg(2+). Mn(2+) cannot be used.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="12 19 21 29">Activated by insulin (By similarity). Only slightly inhibited by wortmannin and LY294002. Activated by clathrin.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="29">122 uM for PtdIns (in the absence of phosphatidylserine)</KM>
<KM evidence="29">64 uM for PtdIns (in the presence of phosphatidylserine)</KM>
<KM evidence="29">25 uM for PtdIns4P (in the presence of phosphatidylserine)</KM>
<KM evidence="29">15 uM for ATP (with PtdIns as substrate) (in the absence of phosphatidylserine)</KM>
<KM evidence="29">32 uM for ATP (with PtdIns as substrate) (in the presence of phosphatidylserine)</KM>
<KM evidence="29">54 uM for ATP (with PtdIns4P as substrate) (in the presence of phosphatidylserine)</KM>
<Vmax evidence="29">990 pmol/min/mg enzyme with PtdIns as substrate (in the absence of phosphatidylserine)</Vmax>
<Vmax evidence="29">200 pmol/min/mg enzyme with PtdIns as substrate (in the presence of phosphatidylserine)</Vmax>
<Vmax evidence="29">240 pmol/min/mg enzyme with PtdIns4P as substrate (in the presence of phosphatidylserine)</Vmax>
<Vmax evidence="29">6800 pmol/min/mg enzyme toward ATP with PtdIns as substrate (in the absence of phosphatidylserine)</Vmax>
<Vmax evidence="29">805 pmol/min/mg enzyme toward ATP with PtdIns as substrate (in the presence of phosphatidylserine)</Vmax>
<Vmax evidence="29">880 pmol/min/mg enzyme toward ATP with PtdIns4P as substrate (in the presence of phosphatidylserine)</Vmax>
<text>In the absence of the carrier phosphatidylserine, enzymatic kinetics toward PtdIns4P are non-linear.</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="20 21 25">Part of a complex with ERBB2 and EGFR. Interacts with clathrin trimers.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19 21 26">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 21">Golgi apparatus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 21">Cytoplasmic vesicle</location>
<location evidence="19 21">Clathrin-coated vesicle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22 24">Cytoplasm</location>
</subcellularLocation>
<text evidence="22 26">Inserts preferentially into membranes containing PtdIns(4,5)P2 (PubMed:17038310). Associated with RNA-containing structures (PubMed:11606566).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O00443-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O00443-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056158"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="24 28 29">Expressed in columnar and transitional epithelia, mononuclear cells, smooth muscle cells, and endothelial cells lining capillaries and small venules (at protein level). Ubiquitously expressed, with highest levels in heart, placenta and ovary, and lowest levels in the kidney. Detected at low levels in islets of Langerhans from type 2 diabetes mellitus individuals.</text>
</comment>
<comment type="PTM">
<text evidence="12 22 23">Phosphorylated upon insulin stimulation; which may lead to enzyme activation (By similarity). Phosphorylated on Ser-259 during mitosis and upon UV irradiation; which does not change enzymatic activity but leads to proteasomal degradation. Ser-259 phosphorylation may be mediated by CDK1 or JNK, depending on the physiological state of the cell.</text>
</comment>
<comment type="similarity">
<text evidence="17 18">Belongs to the PI3/PI4-kinase family.</text>
</comment>
<dbReference type="EC" id="2.7.1.154"/>
<dbReference type="EMBL" id="Y13367">
<property type="protein sequence ID" value="CAA73797.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304262">
<property type="protein sequence ID" value="BAG65126.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU332862">
<property type="protein sequence ID" value="ABY87551.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC107956">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC116533">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC126389">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471064">
<property type="protein sequence ID" value="EAW68447.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113658">
<property type="protein sequence ID" value="AAI13659.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7824.1">
<molecule id="O00443-1"/>
</dbReference>
<dbReference type="PIR" id="PC4345">
<property type="entry name" value="PC4345"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001308307.1">
<molecule id="O00443-1"/>
<property type="nucleotide sequence ID" value="NM_001321378.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002636.2">
<molecule id="O00443-1"/>
<property type="nucleotide sequence ID" value="NM_002645.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016873413.1">
<molecule id="O00443-1"/>
<property type="nucleotide sequence ID" value="XM_017017924.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.175343"/>
<dbReference type="UniGene" id="Hs.736397"/>
<dbReference type="PDB" id="2AR5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1421-1532"/>
</dbReference>
<dbReference type="PDB" id="2IWL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="X=1405-1544"/>
</dbReference>
<dbReference type="PDB" id="2REA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1421-1532"/>
</dbReference>
<dbReference type="PDB" id="2RED">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1421-1532"/>
</dbReference>
<dbReference type="PDBsum" id="2AR5"/>
<dbReference type="PDBsum" id="2IWL"/>
<dbReference type="PDBsum" id="2REA"/>
<dbReference type="PDBsum" id="2RED"/>
<dbReference type="ProteinModelPortal" id="O00443"/>
<dbReference type="SMR" id="O00443"/>
<dbReference type="BioGrid" id="111304">
<property type="interactions" value="62"/>
</dbReference>
<dbReference type="DIP" id="DIP-33727N"/>
<dbReference type="IntAct" id="O00443">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="MINT" id="MINT-2794824"/>
<dbReference type="STRING" id="9606.ENSP00000265970"/>
<dbReference type="BindingDB" id="O00443"/>
<dbReference type="ChEMBL" id="CHEMBL1075102"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2150"/>
<dbReference type="SwissLipids" id="SLP:000000892"/>
<dbReference type="iPTMnet" id="O00443"/>
<dbReference type="PhosphoSitePlus" id="O00443"/>
<dbReference type="BioMuta" id="PIK3C2A"/>
<dbReference type="EPD" id="O00443"/>
<dbReference type="MaxQB" id="O00443"/>
<dbReference type="PaxDb" id="O00443"/>
<dbReference type="PeptideAtlas" id="O00443"/>
<dbReference type="PRIDE" id="O00443"/>
<dbReference type="DNASU" id="5286"/>
<dbReference type="Ensembl" id="ENST00000265970">
<molecule id="O00443-1"/>
<property type="protein sequence ID" value="ENSP00000265970"/>
<property type="gene ID" value="ENSG00000011405"/>
</dbReference>
<dbReference type="GeneID" id="5286"/>
<dbReference type="KEGG" id="hsa:5286"/>
<dbReference type="UCSC" id="uc001mmq.6">
<molecule id="O00443-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5286"/>
<dbReference type="DisGeNET" id="5286"/>
<dbReference type="GeneCards" id="PIK3C2A"/>
<dbReference type="HGNC" id="HGNC:8971">
<property type="gene designation" value="PIK3C2A"/>
</dbReference>
<dbReference type="HPA" id="HPA037641"/>
<dbReference type="HPA" id="HPA037642"/>
<dbReference type="MIM" id="603601">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O00443"/>
<dbReference type="OpenTargets" id="ENSG00000011405"/>
<dbReference type="PharmGKB" id="PA33304"/>
<dbReference type="eggNOG" id="KOG0905">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5032">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119110"/>
<dbReference type="HOGENOM" id="HOG000006920"/>
<dbReference type="HOVERGEN" id="HBG082099"/>
<dbReference type="InParanoid" id="O00443"/>
<dbReference type="KO" id="K00923"/>
<dbReference type="OMA" id="TIQRGQW"/>
<dbReference type="OrthoDB" id="EOG091G00FC"/>
<dbReference type="PhylomeDB" id="O00443"/>
<dbReference type="TreeFam" id="TF102031"/>
<dbReference type="BioCyc" id="MetaCyc:HS00315-MONOMER"/>
<dbReference type="BRENDA" id="2.7.1.154">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660514">
<property type="pathway name" value="Synthesis of PIPs at the Golgi membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660516">
<property type="pathway name" value="Synthesis of PIPs at the early endosome membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660517">
<property type="pathway name" value="Synthesis of PIPs at the late endosome membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-432722">
<property type="pathway name" value="Golgi Associated Vesicle Biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="SABIO-RK" id="O00443"/>
<dbReference type="SIGNOR" id="O00443"/>
<dbReference type="ChiTaRS" id="PIK3C2A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O00443"/>
<dbReference type="GeneWiki" id="PIK3C2A"/>
<dbReference type="GenomeRNAi" id="5286"/>
<dbReference type="PRO" id="PR:O00443"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000011405"/>
<dbReference type="CleanEx" id="HS_PIK3C2A"/>
<dbReference type="ExpressionAtlas" id="O00443">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O00443">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030136">
<property type="term" value="C:clathrin-coated vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005942">
<property type="term" value="C:phosphatidylinositol 3-kinase complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031982">
<property type="term" value="C:vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016303">
<property type="term" value="F:1-phosphatidylinositol-3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0035005">
<property type="term" value="F:1-phosphatidylinositol-4-phosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035004">
<property type="term" value="F:phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035091">
<property type="term" value="F:phosphatidylinositol binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0048268">
<property type="term" value="P:clathrin coat assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006897">
<property type="term" value="P:endocytosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006887">
<property type="term" value="P:exocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008286">
<property type="term" value="P:insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014829">
<property type="term" value="P:vascular smooth muscle contraction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.1070.11">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.150">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.1520.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR016024">
<property type="entry name" value="ARM-type_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR000008">
<property type="entry name" value="C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001683">
<property type="entry name" value="Phox"/>
</dbReference>
<dbReference type="InterPro" id="IPR000403">
<property type="entry name" value="PI3/4_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018936">
<property type="entry name" value="PI3/4_kinase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002420">
<property type="entry name" value="PI3K_C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000341">
<property type="entry name" value="PI3K_Ras-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR015433">
<property type="entry name" value="PI_Kinase"/>
</dbReference>
<dbReference type="InterPro" id="IPR001263">
<property type="entry name" value="PInositide-3_kin_accessory_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-rel_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10048">
<property type="entry name" value="PTHR10048"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00168">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00454">
<property type="entry name" value="PI3_PI4_kinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00792">
<property type="entry name" value="PI3K_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00794">
<property type="entry name" value="PI3K_rbd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00613">
<property type="entry name" value="PI3Ka"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00787">
<property type="entry name" value="PX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00239">
<property type="entry name" value="C2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00142">
<property type="entry name" value="PI3K_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00144">
<property type="entry name" value="PI3K_rbd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00145">
<property type="entry name" value="PI3Ka"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00146">
<property type="entry name" value="PI3Kc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00312">
<property type="entry name" value="PX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48371">
<property type="entry name" value="SSF48371"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49562">
<property type="entry name" value="SSF49562"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF64268">
<property type="entry name" value="SSF64268"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50004">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00915">
<property type="entry name" value="PI3_4_KINASE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00916">
<property type="entry name" value="PI3_4_KINASE_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50290">
<property type="entry name" value="PI3_4_KINASE_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51547">
<property type="entry name" value="PI3K_C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51546">
<property type="entry name" value="PI3K_RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51545">
<property type="entry name" value="PIK_HELICAL"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50195">
<property type="entry name" value="PX"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0268">Exocytosis</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="initiator methionine" description="Removed" evidence="6">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha" id="PRO_0000088795">
<location>
<begin position="2"/>
<end position="1686"/>
</location>
</feature>
<feature type="domain" description="PI3K-RBD" evidence="17">
<location>
<begin position="421"/>
<end position="509"/>
</location>
</feature>
<feature type="domain" description="C2 PI3K-type" evidence="13 18">
<location>
<begin position="682"/>
<end position="841"/>
</location>
</feature>
<feature type="domain" description="PIK helical" evidence="16">
<location>
<begin position="861"/>
<end position="1037"/>
</location>
</feature>
<feature type="domain" description="PI3K/PI4K" evidence="15">
<location>
<begin position="1133"/>
<end position="1397"/>
</location>
</feature>
<feature type="domain" description="PX" evidence="14">
<location>
<begin position="1422"/>
<end position="1538"/>
</location>
</feature>
<feature type="domain" description="C2" evidence="13">
<location>
<begin position="1559"/>
<end position="1662"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with clathrin; sufficient to induce clathrin assemby">
<location>
<begin position="2"/>
<end position="142"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PtdIns(4,5)P2-containing membranes">
<location>
<begin position="1488"/>
<end position="1493"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="22">
<location>
<begin position="1608"/>
<end position="1619"/>
</location>
</feature>
<feature type="site" description="Not phosphorylated" evidence="23">
<location>
<position position="244"/>
</location>
</feature>
<feature type="site" description="Not phosphorylated" evidence="23">
<location>
<position position="249"/>
</location>
</feature>
<feature type="site" description="Not phosphorylated" evidence="23">
<location>
<position position="251"/>
</location>
</feature>
<feature type="site" description="Not phosphorylated" evidence="23">
<location>
<position position="254"/>
</location>
</feature>
<feature type="site" description="Not phosphorylated" evidence="23">
<location>
<position position="262"/>
</location>
</feature>
<feature type="site" description="Not phosphorylated" evidence="23">
<location>
<position position="266"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="6">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="60"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 8 10">
<location>
<position position="108"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 5 7 8 9 10 11 23">
<location>
<position position="259"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10">
<location>
<position position="327"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="338"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="630"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1281"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1553"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056158" evidence="30">
<location>
<begin position="484"/>
<end position="1686"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11604561." id="VAR_023333">
<original>T</original>
<variation>A</variation>
<location>
<position position="1415"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces clathrin binding." evidence="21">
<original>LLLDD</original>
<variation>AAAAA</variation>
<location>
<begin position="103"/>
<end position="107"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation in vitro." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation, no change in activity." evidence="23">
<original>S</original>
<variation>A</variation>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="mutagenesis site" description="Protects from proteolysis." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation in vitro." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation in vitro." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes lipid kinase activity. Affects clathrin distribution when combined with a truncation encompassing the region of clathrin interaction." evidence="25">
<original>D</original>
<variation>A</variation>
<location>
<position position="1250"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces affinity for PtdIns(4,5)P2-containing membranes 7-fold." evidence="26">
<original>R</original>
<variation>A</variation>
<location>
<position position="1488"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces affinity for PtdIns(4,5)P2-containing membranes 7-fold." evidence="26">
<original>V</original>
<variation>A</variation>
<location>
<position position="1490"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces affinity for PtdIns(4,5)P2-containing membranes 5-fold." evidence="26">
<original>L</original>
<variation>A</variation>
<location>
<position position="1491"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces affinity for PtdIns(4,5)P2-containing membranes 23-fold." evidence="26">
<original>R</original>
<variation>A</variation>
<location>
<position position="1493"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PtdIns(4,5)P2-containing membranes." evidence="26">
<original>R</original>
<variation>A</variation>
<location>
<position position="1503"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73797." ref="1" evidence="31">
<original>S</original>
<variation>F</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73797." ref="1" evidence="31">
<original>S</original>
<variation>F</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG65126." ref="2" evidence="31">
<original>N</original>
<variation>K</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73797." ref="1" evidence="31">
<original>F</original>
<variation>C</variation>
<location>
<position position="796"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73797." ref="1" evidence="31">
<original>K</original>
<variation>R</variation>
<location>
<position position="799"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73797." ref="1" evidence="31">
<original>V</original>
<variation>G</variation>
<location>
<position position="922"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73797." ref="1" evidence="31">
<original>M</original>
<variation>L</variation>
<location>
<position position="1129"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73797." ref="1" evidence="31">
<original>R</original>
<variation>W</variation>
<location>
<position position="1450"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA73797." ref="1" evidence="31">
<original>D</original>
<variation>V</variation>
<location>
<position position="1464"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1418"/>
<end position="1421"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1422"/>
<end position="1433"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1437"/>
<end position="1440"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1443"/>
<end position="1450"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1457"/>
<end position="1462"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1463"/>
<end position="1476"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1479"/>
<end position="1481"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1491"/>
<end position="1495"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1498"/>
<end position="1515"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1519"/>
<end position="1522"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1525"/>
<end position="1530"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1535"/>
<end position="1537"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2AR5"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2IWL"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250"/>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00041"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00147"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00269"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00878"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00879"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00880"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10766823"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805725"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11239472"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11606566"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12719431"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14563213"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16215232"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17038310"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21081650"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21127054"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9337861"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<sequence length="1686" mass="190680" checksum="904AA5470F80DAC6" modified="2007-07-10" version="2">
MAQISSNSGFKECPSSHPEPTRAKDVDKEEALQMEAEALAKLQKDRQVTDNQRGFELSSS
TRKKAQVYNKQDYDLMVFPESDSQKRALDIDVEKLTQAELEKLLLDDSFETKKTPVLPVT
PILSPSFSAQLYFRPTIQRGQWPPGLPGPSTYALPSIYPSTYSKQAAFQNGFNPRMPTFP
STEPIYLSLPGQSPYFSYPLTPATPFHPQGSLPIYRPVVSTDMAKLFDKIASTSEFLKNG
KARTDLEITDSKVSNLQVSPKSEDISKFDWLDLDPLSKPKVDNVEVLDHEEEKNVSSLLA
KDPWDAVLLEERSTANCHLERKVNGKSLSVATVTRSQSLNIRTTQLAKAQGHISQKDPNG
TSSLPTGSSLLQEVEVQNEEMAAFCRSITKLKTKFPYTNHRTNPGYLLSPVTAQRNICGE
NASVKVSIDIEGFQLPVTFTCDVSSTVEIIIMQALCWVHDDLNQVDVGSYVLKVCGQEEV
LQNNHCLGSHEHIQNCRKWDTEIRLQLLTFSAMCQNLARTAEDDETPVDLNKHLYQIEKP
CKEAMTRHPVEELLDSYHNQVELALQIENQHRAVDQVIKAVRKICSALDGVETLAITESV
KKLKRAVNLPRSKTADVTSLFGGEDTSRSSTRGSLNPENPVQVSINQLTAAIYDLLRLHA
NSGRSPTDCAQSSKSVKEAWTTTEQLQFTIFAAHGISSNWVSNYEKYYLICSLSHNGKDL
FKPIQSKKVGTYKNFFYLIKWDELIIFPIQISQLPLESVLHLTLFGILNQSSGSSPDSNK
QRKGPEALGKVSLPLFDFKRFLTCGTKLLYLWTSSHTNSVPGTVTKKGYVMERIVLQVDF
PSPAFDIIYTTPQVDRSIIQQHNLETLENDIKGKLLDILHKDSSLGLSKEDKAFLWEKRY
YCFKHPNCLPKILASAPNWKWVNLAKTYSLLHQWPALYPLIALELLDSKFADQEVRSLAV
TWIEAISDDELTDLLPQFVQALKYEIYLNSSLVQFLLSRALGNIQIAHNLYWLLKDALHD
VQFSTRYEHVLGALLSVGGKRLREELLKQTKLVQLLGGVAEKVRQASGSARQVVLQRSME
RVQSFFQKNKCRLPLKPSLVAKELNIKSCSFFSSNAVPLKVTMVNADPMGEEINVMFKVG
EDLRQDMLALQMIKIMDKIWLKEGLDLRMVIFKCLSTGRDRGMVELVPASDTLRKIQVEY
GVTGSFKDKPLAEWLRKYNPSEEEYEKASENFIYSCAGCCVATYVLGICDRHNDNIMLRS
TGHMFHIDFGKFLGHAQMFGSFKRDRAPFVLTSDMAYVINGGEKPTIRFQLFVDLCCQAY
NLIRKQTNLFLNLLSLMIPSGLPELTSIQDLKYVRDALQPQTTDAEATIFFTRLIESSLG
SIATKFNFFIHNLAQLRFSGLPSNDEPILSFSPKTYSFRQDGRIKEVSVFTYHKKYNPDK
HYIYVVRILREGQIEPSFVFRTFDEFQELHNKLSIIFPLWKLPGFPNRMVLGRTHIKDVA
AKRKIELNSYLQSLMNASTDVAECDLVCTFFHPLLRDEKAEGIARSADAGSFSPTPGQIG
GAVKLSISYRNGTLFIMVMHIKDLVTEDGADPNPYVKTYLLPDNHKTSKRKTKISRKTRN
PTFNEMLVYSGYSKETLRQRELQLSVLSAESLRENFFLGGVTLPLKDFNLSKETVKWYQL
TAATYL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>